EX-FILING FEES 2 lifecoreforms-8equityinduc.htm EX-FILING FEES Document
EXHIBIT 107.1

Calculation of Filing Fee Tables

Form S-8
(Form Type)

Lifecore Biomedical, Inc.
(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security TypeSecurity Class TitleFee Calculation Rule
Amount Registered(1)(2)
Proposed Maximum Offering Price Per Unit(3)
Maximum Aggregate Offering PriceFee RateAmount of Registration Fee
Newly Registered Securities
EquityCommon Stock, par value $0.001 per shareRule 457(c) and Rule 457(h)3,475,000$4.96$17,236,0000.0001531$2,638.83
Total Offering Amount:$2,638.83
Total Fee Offsets:$0
Net Fee Due:$2,638.83
(1)Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the registration statement on Form S-8 shall also cover any additional shares of the common stock of Lifecore Biomedical, Inc. (the “Registrant”) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant’s common stock.
(2)Represents 3,475,000 shares of the Registrant’s common stock reserved under the Registrant’s Equity Inducement Plan adopted on March 20, 2024.
(3)Estimated solely for the purpose of calculating the registration fee and computed in accordance with Rule 457(c) and (h) under the Securities Act using the average of the high and low sale prices of the common stock on October 8, 2024, as reported on The Nasdaq Global Select Market.